L. Ananth, N. K. Gurbani, S. Kumar, and B. Gujavarti, “A retrospective study of Warning Letters issued by US FDA over 2015-2017”, Int J Drug Reg Affairs, vol. 6, no. 2, pp. 48-53, Jun. 2018.